BCM
BIIB icon

Bourgeon Capital Management’s Biogen BIIB Stock Holding History

Bourgeon Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,000
Closed -$277K – 332
2022
Q4 		$277K Hold
1,000
– – 0.07% 84
2022
Q3 		$267K Hold
1,000
– – 0.07% 79
2022
Q2 		$204K Hold
1,000
– – 0.05% 89
2022
Q1 		$211K Buy
+1,000
New +$217K 0.05% 93
2020
Q1 		– Sell
-105
Closed -$31K – 256
2019
Q4 		$31K Sell
105
-25
-19% -$6.94K 0.01% 133
2019
Q3 		$30K Buy
+130
New +$30.3K 0.02% 130
2019
Q1 		– Sell
-14,066
Closed -$4.23M – 74
2018
Q4 		$4.23M Sell
14,066
-25
-0.2% -$7.98K 2.77% 15
2018
Q3 		$4.98M Sell
14,091
-5,125
-27% -$1.76M 2.57% 19
2018
Q2 		$5.58M Sell
19,216
-15
-0.1% -$4.22K 3% 14
2018
Q1 		$5.27M Buy
19,231
+5,615
+41% +$1.74M 2.88% 16
2017
Q4 		$4.34M Sell
13,616
-110
-0.8% -$35.3K 2.37% 16
2017
Q3 		$4.3M Buy
13,726
+116
+0.9% +$34.3K 2.53% 15
2017
Q2 		$3.69M Sell
13,610
-10
-0.1% -$2.64K 2.31% 17
2017
Q1 		$3.72M Sell
13,620
-125
-0.9% -$35.3K 2.33% 17
2016
Q4 		$3.9M Buy
13,745
+350
+3% +$104K 2.45% 17
2016
Q3 		$4.19M Sell
13,395
-2,155
-14% -$638K 2.69% 16
2016
Q2 		$3.76M Buy
15,550
+1,590
+11% +$419K 2.44% 18
2016
Q1 		$3.63M Sell
13,960
-330
-2% -$87.2K 2.43% 17
2015
Q4 		$4.38M Buy
14,290
+6,490
+83% +$1.86M 2.81% 11
2015
Q3 		$2.28M Buy
+7,800
New +$2.58M 1.59% 24

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bourgeon Capital Management's BIIB Position: Q1 2023 in Review

Bourgeon Capital Management sold out of Biogen (BIIB) in Q1 2023, closing a stake of 1,000 shares — an estimated $277K sold.

Bourgeon Capital Management first reported a position in BIIB in Q3 2015 and held it in 20 quarters. The position peaked at $5.58M in Q2 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

  • Bourgeon Capital Management reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
  • Bourgeon Capital Management sold 1,000 Biogen shares in Q1 2023, an estimated $277K.
  • Bourgeon Capital Management first reported a position in Biogen in Q3 2015 and held it in 20 quarters.
  • Bourgeon Capital Management's Biogen position peaked at $5.58M in Q2 2018.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on Bourgeon Capital Management's 13F filing for Q1 2023, filed 17 Apr 2023.